Assesses CA-19.9 levels, commonly used as a marker for pancreatic and gastrointestinal cancers.

Measures CA-15.3 levels, a marker associated with breast cancer monitoring.

Detects Bence Jones proteins in urine, which are associated with multiple myeloma and other plasma cell disorders.

Measures the level of prostate-specific antigen in the blood to screen for prostate abnormalities and cancer.

Evaluates the free (unbound) fraction of PSA to help differentiate between benign prostate conditions and cancer.

Assesses AFP levels, a marker used in the screening and monitoring of liver cancer and certain germ cell tumors.

Measures CEA levels, a tumor marker used in diagnosing and monitoring various cancers, particularly colorectal cancer.

Evaluates CA-125 levels, a marker primarily used in the diagnosis and monitoring of ovarian cancer.